INMUNOENSAYO ENZIMÁTICO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS DE CLASE IGG CONTRA TAENIA SOLIUM EN SUERO O PLASMA HUMANO
Mexico·Clase I·III. Agentes de diagnóstico·INOCHEM, S.A. DE
C.V.·Registered November 16, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- TAENIA SOLIUM IGG ELISA
- Trade Name (English)
- TAENIA SOLIUM IGG ELISA
- Analysis ID
- 1424R2022 SSA
- Registration Date
- November 16, 2022
- Name (Spanish)
- INOCHEM, S.A. DE C.V.
- Name (English)
- INOCHEM, S.A. DE C.V.
Access comprehensive regulatory information for INMUNOENSAYO ENZIMÁTICO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS DE CLASE IGG CONTRA TAENIA SOLIUM EN SUERO O PLASMA HUMANO (INMUNOENSAYO ENZIMÁTICO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS DE CLASE IGG CONTRA TAENIA SOLIUM EN SUERO O PLASMA HUMANO) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1424R2022 SSA and manufactured by INOCHEM, S.A. DE C.V.. The device was registered on November 16, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.